SCHEMBL5919947

SCHEMBL5919947

CCCCCCC(=Nc1ccc(CC)c(CC)c1)C(CC)=Nc1ccc(CC)c(CC)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.36
▸ PLA2G2A P14555 1/20 0.36
▸ PLA2G5 P39877 1/20 0.36
▸ CHUK O15111 1/20 0.35
▸ DAPK3 O43293 1/20 0.35
▸ JAK2 O60674 1/20 0.35
▸ ROCK2 O75116 1/20 0.35
▸ PRKCG P05129 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ RPS6KB1 P23443 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ AKT1 P31749 1/20 0.35
▸ AKT2 P31751 1/20 0.35
▸ MAPKAPK2 P49137 1/20 0.35
▸ BLK P51451 1/20 0.35
▸ RPS6KA3 P51812 1/20 0.35
▸ JAK3 P52333 1/20 0.35
▸ LIMK1 P53667 1/20 0.35
▸ PRKCZ Q05513 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5920956 0.99 FFAR1 (0.35) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920811 0.99 FFAR1 (0.35) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920806 0.99 FFAR1 (0.35) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920964 0.99 FFAR1 (0.35) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920794 0.97 CHUK (0.33) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920787 0.97 CHUK (0.33) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5678021 0.95 FFAR1 (0.38) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5676809 0.95 FFAR1 (0.38) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5676408 0.95 FFAR1 (0.38) FFAR1PLA2G2APLA2G5CHUKDAPK3
SCHEMBL5920557 0.95 FFAR1 (0.38) FFAR1PLA2G2APLA2G5CHUKDAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR FFAR1 1944/4885PLA2G2A 4023/4885PLA2G5 4388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback